PLATINUM-RESISTANT OVARIAN CANCER
Clinical trials for PLATINUM-RESISTANT OVARIAN CANCER explained in plain language.
Never miss a new study
Get alerted when new PLATINUM-RESISTANT OVARIAN CANCER trials appear
Sign up with your email to follow new studies for PLATINUM-RESISTANT OVARIAN CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
First-in-Human trial tests engineered immune cells against tough ovarian cancer
Disease control Not yet recruitingThis is a first-in-human study to test the safety and find the right dose of a new cell therapy called GB-5267 for women with ovarian cancer that has stopped responding to platinum chemotherapy. The therapy involves taking a patient's own immune cells (T-cells), engineering them …
Matched conditions: PLATINUM-RESISTANT OVARIAN CANCER
Phase: PHASE1 • Sponsor: Roswell Park Cancer Institute • Aim: Disease control
Last updated Apr 02, 2026 14:56 UTC
-
Could a common heart pill boost chemo against tough ovarian cancer?
Disease control Not yet recruitingThis study is testing if adding losartan, a common blood pressure medication, to standard weekly paclitaxel chemotherapy can better control ovarian cancer that has stopped responding to platinum drugs. It will involve about 27 patients with this advanced, treatment-resistant form…
Matched conditions: PLATINUM-RESISTANT OVARIAN CANCER
Phase: PHASE2 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Mar 31, 2026 12:15 UTC